loading
전일 마감가:
$0.95
열려 있는:
$0.931
하루 거래량:
6,115
Relative Volume:
0.12
시가총액:
$38.22M
수익:
$13.42M
순이익/손실:
$-73.35M
주가수익비율:
-0.5071
EPS:
-1.92
순현금흐름:
$-56.34M
1주 성능:
-9.85%
1개월 성능:
-11.49%
6개월 성능:
-35.09%
1년 성능:
-64.13%
1일 변동 폭
Value
$0.931
$1.00
1주일 범위
Value
$0.92
$1.1088
52주 변동 폭
Value
$0.8008
$4.1591

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile

Name
명칭
Barinthus Biotherapeutics Plc Adr
Name
전화
44 (0) 1865 818808
Name
주소
UNIT 6-10, ZEUS BUILDING, DIDCOT
Name
직원
130
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
BRNS's Discussions on Twitter

BRNS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
BRNS
Barinthus Biotherapeutics Plc Adr
0.9455 38.22M 13.42M -73.35M -56.34M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
440.88 113.70B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
682.90 75.52B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
663.74 39.78B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
275.41 35.34B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
121.57 29.05B 3.30B -501.07M 1.03B -2.1146

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-05-25 개시 Jefferies Buy
2021-05-25 개시 Morgan Stanley Overweight
2021-05-25 개시 William Blair Outperform
2021-05-24 개시 H.C. Wainwright Buy

Barinthus Biotherapeutics Plc Adr 주식(BRNS)의 최신 뉴스

pulisher
Jan 10, 2025

Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com

Jan 10, 2025
pulisher
Nov 15, 2024

New trial shows promise for chronic hepatitis B treatment - Investing.com India

Nov 15, 2024
pulisher
Oct 01, 2024

Barinthus Bio completes enrollment for two clinical trials - Investing.com India

Oct 01, 2024
pulisher
Sep 25, 2024

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer

Sep 25, 2024
pulisher
Sep 24, 2024

Barinthus Bio launches Phase 1 celiac disease therapy trial - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Barinthus Biotherapeutics Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease - Investing.com

Sep 24, 2024
pulisher
Sep 05, 2024

Barinthus Biotherapeutics appoints new COO - Investing.com

Sep 05, 2024
pulisher
Sep 05, 2024

BRNS Stock Touches 52-Week Low at $1.14 Amid Market Challenges - Investing.com UK

Sep 05, 2024
pulisher
Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 21, 2024
pulisher
May 01, 2024

Kintara Therapeutics restructures share designations By Investing.com - Investing.com

May 01, 2024
pulisher
Mar 18, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 18, 2024
pulisher
Mar 13, 2024

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates - Yahoo Finance

Mar 13, 2024
pulisher
Apr 30, 2021

Vaccitech (VACC) Stock Price, News & Analysis - MarketBeat

Apr 30, 2021
pulisher
Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011

Barinthus Biotherapeutics Plc Adr (BRNS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$41.32
price up icon 0.42%
$22.23
price up icon 2.93%
$353.66
price down icon 4.93%
$5.32
price up icon 2.30%
biotechnology ONC
$227.80
price up icon 0.51%
$120.53
price down icon 0.02%
자본화:     |  볼륨(24시간):